Search Results - "Flynn, Jeremy D"

Refine Results
  1. 1

    Methylene Blue for the Treatment of Septic Shock by Paciullo, Christopher A., Horner, Deanna McMahon, Hatton, Kevin W., Flynn, Jeremy D.

    Published in Pharmacotherapy (01-07-2010)
    “…Septic shock is a major cause of morbidity and mortality in the intensive care unit, and effective therapies are limited. Methylene blue is a selective…”
    Get full text
    Journal Article
  2. 2

    Malignant Hyperthermia: A Pharmacogenetic Disorder by STRATMAN, Rachel C, FLYNN, Jeremy D, HATTON, Kevin W

    Published in Orthopedics (Thorofare, N.J.) (01-11-2009)
    “…[...]patients commonly develop myoglobinemia, myoglobinuria, hyperkalemia, hyperphosphatemia, and hypocalcemia. Other disorders that resemble malignant…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Managing the Rising Costs and High Drug Expenditures in Critical Care Pharmacy Practice by Flannery, Alexander H., Pandya, Komal, Laine, Melanie E., Almeter, Philip J., Flynn, Jeremy D.

    Published in Pharmacotherapy (01-01-2017)
    “…Pharmaceutical costs for patients in the intensive care unit (ICU) constitute a large portion of hospital drug budgets. Unfortunately, prices for medications…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Severe Hypertriglyceridemia Induced by Sirolimus Treated With Medical Management Without Plasmapheresis: A Case Report by Kido, Kazuhiko, Evans, Rickey A., Gopinath, Anil, Flynn, Jeremy D.

    Published in Journal of pharmacy practice (01-02-2018)
    “…Hypertriglyceridemia and hyperlipidemia are the most remarkable metabolic complications seen with long-term sirolimus therapy. We report the case of a…”
    Get full text
    Journal Article
  7. 7

    Impact of Pharmacist Intervention on Selection and Timing of Appropriate Antimicrobial Therapy in Septic Shock by Laine, Melanie E., Flynn, Jeremy D., Flannery, Alexander H.

    Published in Journal of pharmacy practice (01-02-2018)
    “…Background: Current guidelines for septic shock management recommend administration of appropriate, broad-spectrum antimicrobials within 1 hour of recognition…”
    Get full text
    Journal Article
  8. 8

    More Questions Than Answers in ICU Delirium: Pressing Issues for Future Research by Flannery, Alexander H., Flynn, Jeremy D.

    Published in The Annals of pharmacotherapy (01-11-2013)
    “…With the release of the updated pain, agitation, and delirium guidelines by the Society of Critical Care Medicine, a number of new and updated recommendations…”
    Get full text
    Journal Article
  9. 9

    Utilization of Pharmacist Responders as a Component of a Multidisciplinary Sepsis Bundle by Flynn, Jeremy D., McConeghy, Kevin W., Flannery, Alexander H., Nestor, Melissa, Branson, Pam, Hatton, Kevin W.

    Published in The Annals of pharmacotherapy (01-09-2014)
    “…Background: Sepsis and septic shock remain a significant burden on the US health care system. A multidisciplinary response system (Coordinated Response to…”
    Get full text
    Journal Article
  10. 10

    Fondaparinux as a Treatment Option for Heparin-Induced Thrombocytopenia by Papadopoulos, Stella, Flynn, Jeremy D., Lewis, Daniel A.

    Published in Pharmacotherapy (01-06-2007)
    “…Heparin‐induced thrombocytopenia (HIT) is an immune‐mediated complication that can occur after exposure to heparin products. Because patients with HIT are at…”
    Get full text
    Journal Article
  11. 11

    A clinical-laboratory algorithm incorporating optical density value to predict heparin-induced thrombocytopenia by Ruf, Kathryn M, Bensadoun, Eric S, Davis, George A, Flynn, Jeremy D, Lewis, Daniel A

    Published in Thrombosis and haemostasis (01-03-2011)
    “…The diagnosis of heparin-induced thrombocytopenia (HIT) is complex and involves integrating both clinical and laboratory findings. Readily available diagnostic…”
    Get more information
    Journal Article
  12. 12

    Pharmacotherapy of Lung Transplantation: An Overview by Thompson, Melissa L., Flynn, Jeremy D., Clifford, Timothy M.

    Published in Journal of pharmacy practice (01-02-2013)
    “…Lung transplantation has become a viable treatment therapy for end-stage lung disease patients. The most common etiologies of end-stage lung disease, which can…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Recombinant Factor VIIa for Refractory Bleeding After Cardiac Surgery Secondary to Anticoagulation with the Direct Thrombin Inhibitor Lepirudin by Oh, Jennifer J., Akers, Wendell S., Lewis, Daniel, Ramaiah, Chand, Flynn, Jeremy D.

    Published in Pharmacotherapy (01-04-2006)
    “…A 56‐year‐old man with heparin‐induced thrombocytopenia with thrombosis syndrome (HITTS) received anticoagulation with recombinant hirudin (lepirudin) for…”
    Get full text
    Journal Article
  15. 15

    Interventions to improve guideline compliance following coronary artery bypass grafting by Yam, Felix K., Akers, Wendell S., Ferraris, Victor A., Smith, Kelly, Ramaiah, Chand, Camp, Phillip, Flynn, Jeremy D.

    Published in Surgery (01-10-2006)
    “…Lifestyle modification and appropriate medical therapy improve long-term outcomes following coronary artery bypass grafting (CABG). Our institutional…”
    Get full text
    Journal Article
  16. 16

    Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole by Hayes, Jr, Don, Ball, Amanda M, Mansour, Heidi M, Martin, Craig A, Flynn, Jeremy D

    “…Heart and lung transplant recipients are at risk for invasive fungal infections. This study evaluated the affect of single-agent antifungal prophylaxis with…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Effects of the Angiotensin II Subtype 1 Receptor Antagonist Losartan on Functional Recovery of Isolated Rat Hearts Undergoing Global Myocardial Ischemia-Reperfusion by Flynn, Jeremy D., Akers, Wendell S.

    Published in Pharmacotherapy (01-11-2003)
    “…Study Objective. To investigate the effects of the angiotensin II subtype 1 receptor (AT1R) antagonist losartan on functional recovery of isolated rat hearts…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Treatment of Respiratory Syncytial Virus Pneumonia in a Lung Transplant Recipient: Case Report and Review of the Literature by Flynn, Jeremy D., Akers, Wendell S., Jones, Mikael, Stevkovic, Natasa, Waid, Thomas, Mullett, Timothy, Jahania, Salik

    Published in Pharmacotherapy (01-07-2004)
    “…A 61‐year‐old woman who underwent lung transplantation developed severe respiratory syncytial virus (RSV) pneumonia and experienced respiratory failure…”
    Get full text
    Journal Article